To be very honest with you guys: In the long run things have only gotten better, they will make more profits next year with less revenue. So if they get revenues growing again (after 2010) because for example Hongrui will be attributing more, the profits will be even bigger!!
The huge amount of 100+ Million in cash is nice: what can we buy or what medicines can be developed with that kind of money ?!
Finally one of the four pending new drugs is almost SFDA approved!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.